Colour Vision of Diabetics – Capstone Project Example

Download full paperFile format: .doc, available for editing

The paper "Colour Vision of Diabetics ' is a great example of a capstone project on health sciences and medicine.   Abstract This paper delves upon an extensive review of Diabetes and its related effects. The paper also provides a good view of Diabetes and the Color vision and the tests. There is a section of the analysis of the Human Eye. A conclusion and a bibliography are appended at the end. Diabetes: An Introduction An estimated 16 million people in the United States have diabetes mellitus a serious, permanent condition. About half of these people do not know they have diabetes and are not under care for the ailment.

Each year, about 798,000 people are diagnosed with diabetes. Despite the fact that diabetes takes place most frequently in older adults, it is one of the most recurrent chronic disorders in children in the United States. Nearly 123,000 children and teenagers age 19 and younger have diabetes. Diabetes is one of the primary causes of death and disability in the United States, contributing to the deaths of almost 200,000 persons a year. Diabetes is generally considered as permanent and all effort is directed at controlling or managing it.

Nevertheless, it is now believed not only that most cases are curable although that early diabetes 1 and all diabetes 2 are rather easy to treat with a suitable diet. In other words, radical diet changes are required to take on as much as possible a more natural diet. For some this is easy and a small price to pay for the recovery of health, at the same time as for others it is not worth living without their favorite foods, and for these, the accepted medical treatment will be best. ‘ Diabetes mellitus creates a considerable clinical and economic burden on society’ (Songer and Ettaro, 1998; American Diabetes Association, 296-309; Rubin et al, 809A-809F).

‘ For 1998, direct and indirect expenses of diabetes mellitus and its complications are estimated at $98.2 billion in the United States’ (Songer and Ettaro, 1998; American Diabetes Association, 296-309). ‘ Standards of care for diabetes mellitus have been generally disseminated since the 1980s’ (American Diabetes Association, 296-309)in the belief that ‘ improved processes of care can improve patient outcomes’ (Alberti and Zimmet, 539-553; Conseil Superieur du Diabetes, 539-553), however ‘ primary care providers have been slow to apply patient care guidelines and recommendations’ .

References

Aiello L. P, Bursell S. E, Clermont A, et al. Vascular endothelial growth factor induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor, 1997:1473-80, Diabetes. 46(9).

Alberti, K. G; Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, 1998:539-553, Diabet Med; 15.

American Diabetes Association. Economic consequences of diabetes mellitus in the US in 1997, 1998: 296-309, Diabetes Care; 21.

Anderson, R. M; Donnelly, M. B; Dedrick, R. F; Gressard, C. P. The attitudes of nurses, dietitians, and physicians toward diabetes, 1991: 261-268, Diabetes Educ; 17.

Anderson, R. M, Donnelly, M. B; Davis, W. K. Controversial beliefs about diabetes and its care, 1992:859-863, Diabetes Care; 15.

Baynes, J. W., Bunn, H.F., Goldstein, D. et al. National Diabetes Data Group: report of the expert committee on glucosylated hemoglobin, 1984:602-606, Diabetes Care; 7.

Boulton, A. J. M., Malik, R. A., Arezzo, J. C., Sosenko, J. M. Diabetic somatic neuropathies, 2004:1258-1486, Diabetes Care; 27.

Cavallerano, J., Ramachandiran, C., eds. Optometric clinical practice guideline, care of the patient with diabetes mellitus, 2002.

Ciardella, A. P. Klancnik, J., Schiff, W., et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study, 2004:1131-6, Br J Ophthalmol. 88(9).

Ciulla, T. A., Amador, A. G., Zinman, B. Diabetic retinopathy and diabetic macular edema, 2003:2653-2664, Diabetes Care; 26.

Conseil Superieur du Diabete. Diabetes care and research in Europe: the St. Vincent Declaration Action Program [in French], 1992: 334-377, Diabetes Metab; 18.

Datiles, M. B., Magno, B. V. Cataract: clinical types. In: Tasman W, Jaeger EA, eds. Duane’s Ophthalmology CD-ROM, 2000:73, Philadelphia: Lippincott Williams & Wilkins; 1.

Feman, S. S. Diabetes and the eye. In: Tasman W, Jaeger EA, eds. Duane’s Ophthalmology CD-ROM, 2000:20, Philadelphia: Lippincott Williams & Wilkins; 5.

Fritsche, P., Van, Der, Heijde R., Suttorp-Schulten, Polak, B. C. Retinal thickness analysis (RTA): An objective method to assess and quantify the retinal thickness in healthy controls and in diabetics without diabetic retinopathy, 2002:768-771, Retina; 22.

Golin, C. E; DiMatteo, M. R; Gelberg, L. The role of patient participation in the doctor visit: implications for adherence to diabetes care, 1996: 1153-1164, Diabetes Care; 19.

Helseth, L. D; Susman, J. L; Crabtree, B. F; O'Connor, P. J. Primary care physicians' perceptions of diabetes management: a balancing act, 1999:37-42, J Fam Pract; 48.

Kakizawa, H, Itoh Y, Imamura S, et al. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients, 2004:550-5, Metabolism. 53(5).

Karpecki, P. M; Nelson, R. C. Extend diabetic care beyond retinopathy, 2004:100-112 Review of Optometry; 9.

Kenny, S. J; Smith, P. J; Goldschmid, M. G; Newman, J. M; Herman, W. H. Survey of physician practice behaviors related to diabetes mellitus in the US: physician adherence to consensus recommendations, 1993:1507-1510, Diabetes Care; 16.

Kincaid, M. C. Pathology of diabetes mellitus. In: Tasman W, Jaeger EA, eds. Duane’s Ophthalmology CD-ROM, 2000:18, Philadelphia: Lippincott Williams &Wilkins; 3.

Neely, K. A., Gardner, T. W, Brod, R. D., Quillen, D. A. Retinal vascular diseases. In: Quillen, DA, Blodi, BA, eds. Clinical Retina, 2002:126-133, AMA Press.

O'Connor, P. J. From blame to understanding: moving diabetes care forward, 1998:205-206, J Fam Pract; 46.

Pacheco, C. A., Parrott, M. A., Raskin, P. The treatment of hypertension in adult patients with diabetes, 2002:124-147, Diabetes Care; 25.

Rosen, R. B. Sander, B. The RTA in managing diabetic macular edema, 2001:6-7, Review of Ophthalmology Suppl; 8.

Rubin, R. J; Altman, W. M; Mendelson, D. N. Health care expenditures for people with diabetes mellitus, 1992:809A-809F, J Clin Endocrinol Metab; 78.

Songer T. J, Ettaro, L. Economics of Diabetes Project Panel, Studies on the Costs of Diabetes, 1998, Atlanta, Ga: Centers for Disease Control and Prevention.

Stolar, M. W; Endocrine Fellows Foundation Study Group. Clinical management of the NIDDM patient: impact of the American Diabetes Association practice guidelines, 1985-1993, 1995:701-707, Diabetes Care; 18.

Wing, R. R; Epstein, L. H; Nowalk, M. P; Scott, N; Koeske, R. Compliance to selfmonitoring of blood glucose: a marked-item technique compared with self-report, 1985:456-460, Diabetes Care; 8.

Download full paperFile format: .doc, available for editing
Contact Us